Biotechnology
The Biotechnology industry has a total of 593 stocks, with a combined market cap of $1.14 trillion and total revenue of $110.26 billion.
Market Cap
1.14T
Revenue
110.26B
Profits
-39.74B
PE Ratio
n/a
Profit Margin
-36.04%
Dividend Yield
0.04%
593 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 109.03B | 0.62% | 377,287 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 74.65B | -1.44% | 261,918 | 14.34B |
| 3 | ARGX | argenx SE | 48.47B | -1.58% | 146,177 | 4.24B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 40.35B | -1.99% | 442,479 | 3.71B |
| 5 | ONC | BeOne Medicines AG | 33.12B | -0.07% | 90,439 | 5.34B |
| 6 | RVMD | Revolution Medicines, Inc. | 30.60B | 10.50% | 4,261,963 | - |
| 7 | RPRX | Royalty Pharma plc | 29.42B | -0.06% | 1,520,026 | 2.38B |
| 8 | INSM | Insmed Incorporated | 28.95B | -1.38% | 761,969 | 606.42M |
| 9 | BNTX | BioNTech SE | 25.66B | -0.59% | 279,892 | 3.37B |
| 10 | ROIV | Roivant Sciences Ltd. | 20.02B | 0.43% | 2,702,590 | 13.31M |
| 11 | INCY | Incyte Corporation | 18.81B | -1.23% | 1,417,851 | 5.36B |
| 12 | MRNA | Moderna, Inc. | 18.78B | -2.75% | 2,339,872 | 1.94B |
| 13 | SMMT | Summit Therapeutics Inc. | 16.64B | -3.07% | 1,712,737 | - |
| 14 | GMAB | Genmab A/S | 16.26B | 0.64% | 1,143,341 | 3.72B |
| 15 | ASND | Ascendis Pharma A/S | 13.84B | -1.18% | 1,617,622 | 845.52M |
| 16 | BBIO | BridgeBio Pharma, Inc. | 13.68B | -5.30% | 9,983,034 | 502.08M |
| 17 | JAZZ | Jazz Pharmaceuticals plc | 12.48B | 0.72% | 278,479 | 4.27B |
| 18 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.91B | -0.17% | 84,316 | 958.40M |
| 19 | IONS | Ionis Pharmaceuticals, Inc. | 11.81B | -1.04% | 1,070,556 | 943.71M |
| 20 | EXEL | Exelixis, Inc. | 11.46B | 1.01% | 1,086,849 | 2.32B |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 10.29B | -1.01% | 416,061 | 3.22B |
| 22 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.75B | -5.43% | 940,775 | 1.09B |
| 23 | AXSM | Axsome Therapeutics, Inc. | 9.36B | -2.38% | 391,897 | 638.50M |
| 24 | PRAX | Praxis Precision Medicines, Inc. | 8.94B | -3.05% | 260,541 | 7.46M |
| 25 | ABVX | ABIVAX Société Anonyme | 8.86B | -0.61% | 382,388 | 5.37M |
| 26 | PCVX | Vaxcyte, Inc. | 8.46B | -1.57% | 442,851 | - |
| 27 | TECH | Bio-Techne Corporation | 8.37B | -2.97% | 858,222 | 1.22B |
| 28 | NUVL | Nuvalent, Inc. | 8.02B | -1.96% | 192,733 | - |
| 29 | KRYS | Krystal Biotech, Inc. | 7.93B | -1.24% | 81,191 | 389.13M |
| 30 | CYTK | Cytokinetics, Incorporated | 7.67B | 0.24% | 1,148,986 | 88.04M |
| 31 | HALO | Halozyme Therapeutics, Inc. | 7.48B | -2.11% | 752,968 | 1.40B |
| 32 | IBRX | ImmunityBio, Inc. | 7.24B | -3.84% | 8,305,802 | 113.29M |
| 33 | KYMR | Kymera Therapeutics, Inc. | 6.89B | -2.68% | 228,474 | 39.21M |
| 34 | ACLX | Arcellx, Inc. | 6.75B | - | - | 22.29M |
| 35 | PTGX | Protagonist Therapeutics, Inc. | 6.46B | 2.76% | 243,546 | 46.02M |
| 36 | APGE | Apogee Therapeutics, Inc. | 6.34B | -0.72% | 501,970 | - |
| 37 | BLTE | Belite Bio, Inc | 6.20B | -3.35% | 94,198 | - |
| 38 | TERN | Terns Pharmaceuticals, Inc. | 6.12B | 0.03% | 3,667,281 | - |
| 39 | CNTA | Centessa Pharmaceuticals plc | 6.11B | -0.05% | 730,589 | 15.00M |
| 40 | SYRE | Spyre Therapeutics, Inc. | 6.03B | -2.70% | 402,911 | - |
| 41 | COGT | Cogent Biosciences, Inc. | 5.90B | 0.10% | 800,588 | - |
| 42 | CELC | Celcuity Inc. | 5.82B | -4.14% | 434,216 | - |
| 43 | PTCT | PTC Therapeutics, Inc. | 5.82B | 1.42% | 1,095,548 | 1.73B |
| 44 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.75B | -1.24% | 157,902 | 189.76M |
| 45 | MIRM | Mirum Pharmaceuticals, Inc. | 5.74B | 1.75% | 412,478 | 521.31M |
| 46 | CGON | CG Oncology, Inc. | 5.57B | -1.21% | 284,753 | 4.04M |
| 47 | IMVT | Immunovant, Inc. | 5.54B | -4.82% | 1,377,023 | - |
| 48 | SRRK | Scholar Rock Holding Corporation | 5.39B | 1.32% | 581,133 | - |
| 49 | CAI | Caris Life Sciences, Inc. | 5.28B | -6.27% | 1,028,481 | 812.03M |
| 50 | APLS | Apellis Pharmaceuticals, Inc. | 5.24B | -0.02% | 2,060,627 | 1.00B |
| 51 | XENE | Xenon Pharmaceuticals Inc. | 5.20B | 0.39% | 498,192 | 7.50M |
| 52 | TGTX | TG Therapeutics, Inc. | 5.14B | -1.70% | 1,200,390 | 616.29M |
| 53 | CORT | Corcept Therapeutics Incorporated | 5.01B | 0.95% | 362,894 | 761.41M |
| 54 | CRSP | CRISPR Therapeutics AG | 4.98B | 1.49% | 926,565 | 3.51M |
| 55 | LGND | Ligand Pharmaceuticals Incorporated | 4.68B | -3.32% | 108,585 | 268.09M |
| 56 | DNTH | Dianthus Therapeutics, Inc. | 4.58B | -3.57% | 251,656 | 2.04M |
| 57 | FOLD | Amicus Therapeutics, Inc. | 4.55B | 0.21% | 5,285,334 | 634.21M |
| 58 | LEGN | Legend Biotech Corporation | 4.40B | 0.59% | 1,772,187 | 1.03B |
| 59 | MANE | Veradermics, Incorporated | 3.99B | 6.69% | 821,843 | - |
| 60 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.96B | -1.95% | 1,105,547 | 7.70M |
| 61 | ACAD | ACADIA Pharmaceuticals Inc. | 3.83B | 0.85% | 640,756 | 1.07B |
| 62 | TVTX | Travere Therapeutics, Inc. | 3.82B | 1.23% | 594,352 | 490.73M |
| 63 | VKTX | Viking Therapeutics, Inc. | 3.81B | -0.42% | 1,145,250 | - |
| 64 | ORKA | Oruka Therapeutics, Inc. | 3.80B | -0.85% | 1,860,731 | - |
| 65 | TNGX | Tango Therapeutics, Inc. | 3.59B | -5.36% | 1,923,101 | 62.38M |
| 66 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.59B | 0.55% | 1,303,685 | 588.99M |
| 67 | TLX | Telix Pharmaceuticals Limited | 3.59B | 0.38% | 47,259 | 803.79M |
| 68 | EWTX | Edgewise Therapeutics, Inc. | 3.28B | -0.33% | 1,325,892 | - |
| 69 | NAMS | NewAmsterdam Pharma Company N.V. | 3.21B | -8.44% | 825,071 | 22.50M |
| 70 | DNLI | Denali Therapeutics Inc. | 3.16B | -0.05% | 620,558 | - |
| 71 | GPCR | Structure Therapeutics Inc. | 3.13B | -2.47% | 506,328 | - |
| 72 | RCUS | Arcus Biosciences, Inc. | 3.10B | -1.20% | 1,062,749 | 247.00M |
| 73 | ERAS | Erasca, Inc. | 3.10B | -47.99% | 42,971,434 | - |
| 74 | ALMS | Alumis Inc. | 3.08B | -2.18% | 722,977 | 24.05M |
| 75 | BEAM | Beam Therapeutics Inc. | 3.08B | 5.23% | 1,683,872 | 139.74M |
| 76 | DYN | Dyne Therapeutics, Inc. | 2.98B | -0.06% | 1,177,651 | - |
| 77 | ARQT | Arcutis Biotherapeutics, Inc. | 2.88B | -1.60% | 568,918 | 376.07M |
| 78 | KLRA | Kailera Therapeutics, Inc. | 2.86B | -1.79% | 196,140 | - |
| 79 | NKTR | Nektar Therapeutics | 2.82B | -3.60% | 675,403 | 55.23M |
| 80 | KOD | Kodiak Sciences Inc. | 2.80B | 2.68% | 267,174 | - |
| 81 | SLNO | Soleno Therapeutics, Inc. | 2.73B | 0.05% | 680,601 | 190.41M |
| 82 | VERA | Vera Therapeutics, Inc. | 2.66B | -0.67% | 1,050,744 | - |
| 83 | IMNM | Immunome, Inc. | 2.65B | -0.21% | 283,454 | 6.94M |
| 84 | CLDX | Celldex Therapeutics, Inc. | 2.63B | -0.27% | 409,552 | 1.55M |
| 85 | TARS | Tarsus Pharmaceuticals, Inc. | 2.63B | 1.48% | 284,520 | 451.36M |
| 86 | ELVN | Enliven Therapeutics, Inc. | 2.60B | -3.27% | 331,476 | - |
| 87 | IRON | Disc Medicine, Inc. | 2.58B | -1.92% | 195,464 | - |
| 88 | IDYA | IDEAYA Biosciences, Inc. | 2.57B | -0.92% | 360,083 | 218.71M |
| 89 | ADMA | ADMA Biologics, Inc. | 2.52B | -0.73% | 1,959,625 | 510.17M |
| 90 | ZLAB | Zai Lab Limited | 2.48B | 1.05% | 302,321 | 460.16M |
| 91 | RLAY | Relay Therapeutics, Inc. | 2.47B | -12.51% | 4,312,608 | 15.36M |
| 92 | RARE | Ultragenyx Pharmaceutical Inc. | 2.42B | 2.67% | 878,338 | 673.00M |
| 93 | SRPT | Sarepta Therapeutics, Inc. | 2.22B | 0.67% | 1,326,417 | 2.20B |
| 94 | ADPT | Adaptive Biotechnologies Corporation | 2.16B | -1.27% | 739,903 | 276.98M |
| 95 | AAPG | Ascentage Pharma Group International | 2.16B | -1.58% | 3,177 | 82.08M |
| 96 | MLYS | Mineralys Therapeutics, Inc. | 2.13B | -4.15% | 724,166 | - |
| 97 | TYRA | Tyra Biosciences, Inc. | 2.13B | -3.18% | 358,574 | - |
| 98 | DFTX | Definium Therapeutics, Inc. | 2.11B | 0.95% | 921,305 | - |
| 99 | AUPH | Aurinia Pharmaceuticals Inc. | 2.09B | -1.59% | 500,102 | 283.06M |
| 100 | ZYME | Zymeworks Inc. | 2.07B | -1.61% | 179,819 | 105.97M |
| 101 | OCUL | Ocular Therapeutix, Inc. | 2.01B | -2.99% | 1,076,179 | 51.95M |
| 102 | MESO | Mesoblast Limited | 2.00B | -0.78% | 55,571 | 65.38M |
| 103 | STOK | Stoke Therapeutics, Inc. | 1.97B | -0.98% | 177,000 | 184.42M |
| 104 | CAPR | Capricor Therapeutics, Inc. | 1.95B | -3.99% | 468,307 | 11.13M |
| 105 | TRVI | Trevi Therapeutics, Inc. | 1.92B | -3.85% | 703,987 | - |
| 106 | INBX | Inhibrx Biosciences, Inc. | 1.91B | -0.45% | 255,219 | 1.30M |
| 107 | ANAB | AnaptysBio, Inc. | 1.91B | -0.30% | 381,772 | 234.60M |
| 108 | GLPG | Galapagos NV | 1.89B | 0.28% | 94,019 | 1.31B |
| 109 | PHVS | Pharvaris N.V. | 1.86B | -0.87% | 160,873 | - |
| 110 | SNDX | Syndax Pharmaceuticals, Inc. | 1.86B | 0.33% | 434,360 | 172.35M |
| 111 | PVLA | Palvella Therapeutics, Inc. | 1.83B | -0.71% | 225,402 | - |
| 112 | RXRX | Recursion Pharmaceuticals, Inc. | 1.82B | -1.01% | 5,869,305 | 74.68M |
| 113 | VCEL | Vericel Corporation | 1.82B | -3.28% | 338,109 | 276.26M |
| 114 | SION | Sionna Therapeutics, Inc. | 1.80B | 1.82% | 203,529 | - |
| 115 | NRIX | Nurix Therapeutics, Inc. | 1.79B | 4.94% | 630,889 | 71.78M |
| 116 | TSHA | Taysha Gene Therapies, Inc. | 1.79B | -3.64% | 1,271,195 | 9.77M |
| 117 | HRMY | Harmony Biosciences Holdings, Inc. | 1.78B | -0.90% | 274,486 | 868.45M |
| 118 | INVA | Innoviva, Inc. | 1.75B | 0.88% | 296,722 | 411.33M |
| 119 | VIR | Vir Biotechnology, Inc. | 1.65B | -3.95% | 937,781 | 68.56M |
| 120 | NBTX | Nanobiotix S.A. | 1.61B | -0.33% | 154,746 | 38.27M |
| 121 | NTLA | Intellia Therapeutics, Inc. | 1.61B | 4.68% | 9,061,779 | 67.67M |
| 122 | RAPP | Rapport Therapeutics, Inc. | 1.60B | -5.31% | 127,387 | - |
| 123 | GENB | Generate Biomedicines, Inc. | 1.59B | -0.04% | 193,424 | 31.89M |
| 124 | OCS | Oculis Holding AG | 1.58B | -1.47% | 127,157 | 1.51M |
| 125 | NUVB | Nuvation Bio Inc. | 1.58B | -0.66% | 2,958,716 | 62.90M |
| 126 | IMTX | Immatics N.V. | 1.55B | 2.03% | 125,816 | 56.67M |
| 127 | ATAI | AtaiBeckley Inc. | 1.55B | -1.96% | 2,371,903 | 4.09M |
| 128 | GLUE | Monte Rosa Therapeutics, Inc. | 1.50B | -2.57% | 382,740 | 123.67M |
| 129 | IMCR | Immunocore Holdings plc | 1.48B | 1.89% | 160,437 | 400.02M |
| 130 | DMRA | Damora Therapeutics, Inc. | 1.47B | -4.31% | 64,031 | - |
| 131 | ARDX | Ardelyx, Inc. | 1.47B | -0.25% | 1,049,942 | 407.32M |
| 132 | BHVN | Biohaven Ltd. | 1.44B | - | 780,888 | - |
| 133 | BCAX | Bicara Therapeutics Inc. | 1.44B | -2.34% | 98,228 | - |
| 134 | AGIO | Agios Pharmaceuticals, Inc. | 1.44B | 0.37% | 351,641 | 54.03M |
| 135 | MAZE | Maze Therapeutics, Inc. | 1.43B | -2.53% | 452,826 | 2.50M |
| 136 | PGEN | Precigen, Inc. | 1.42B | 1.64% | 974,422 | 9.68M |
| 137 | MBX | MBX Biosciences, Inc. | 1.42B | -6.62% | 620,453 | - |
| 138 | WVE | Wave Life Sciences Ltd. | 1.39B | 4.32% | 3,330,517 | 71.80M |
| 139 | IOVA | Iovance Biotherapeutics, Inc. | 1.39B | -1.46% | 8,589,432 | 263.50M |
| 140 | VRDN | Viridian Therapeutics, Inc. | 1.39B | -0.44% | 2,095,569 | 70.85M |
| 141 | MPLT | MapLight Therapeutics, Inc. | 1.34B | -0.78% | 113,657 | - |
| 142 | CRVS | Corvus Pharmaceuticals, Inc. | 1.32B | -1.07% | 590,732 | - |
| 143 | JBIO | Jade Biosciences, Inc. | 1.31B | -0.73% | 361,514 | - |
| 144 | AVBP | ArriVent BioPharma, Inc. | 1.30B | -2.70% | 272,472 | - |
| 145 | OLMA | Olema Pharmaceuticals, Inc. | 1.30B | -2.29% | 469,146 | - |
| 146 | NVAX | Novavax, Inc. | 1.30B | -1.24% | 2,211,972 | 1.12B |
| 147 | SVRA | Savara Inc. | 1.28B | -2.23% | 376,766 | - |
| 148 | ABCL | AbCellera Biologics Inc. | 1.26B | -0.48% | 9,710,627 | 75.13M |
| 149 | DBVT | DBV Technologies S.A. | 1.22B | 2.40% | 105,754 | 5.64M |
| 150 | GHRS | GH Research PLC | 1.21B | -0.20% | 110,689 | - |
| 151 | MLTX | MoonLake Immunotherapeutics | 1.21B | 0.36% | 196,061 | - |
| 152 | PHAR | Pharming Group N.V. | 1.17B | -3.01% | 1,059 | 376.13M |
| 153 | URGN | UroGen Pharma Ltd. | 1.16B | 0.15% | 309,603 | 109.79M |
| 154 | QURE | uniQure N.V. | 1.14B | 0.81% | 560,207 | 16.10M |
| 155 | EYPT | EyePoint, Inc. | 1.13B | -0.62% | 248,906 | 31.37M |
| 156 | SEPN | Septerna, Inc. | 1.08B | -4.07% | 132,985 | 45.95M |
| 157 | ZBIO | Zenas BioPharma, Inc. | 1.06B | -4.25% | 247,447 | 10.00M |
| 158 | IVA | Inventiva S.A. | 1.05B | -1.85% | 60,949 | 7.94M |
| 159 | OMER | Omeros Corporation | 1.05B | -1.36% | 1,186,489 | - |
| 160 | XERS | Xeris Biopharma Holdings, Inc. | 1.04B | -1.06% | 576,711 | 291.85M |
| 161 | AKTS | Aktis Oncology, Inc. | 1.04B | -6.67% | 183,069 | 6.50M |
| 162 | FTRE | Fortrea Holdings Inc. | 1.00B | 1.32% | 917,463 | 2.72B |
| 163 | ANNX | Annexon, Inc. | 978.29M | -1.31% | 1,395,147 | - |
| 164 | KALV | KalVista Pharmaceuticals, Inc. | 975.28M | -0.63% | 439,145 | 73.62M |
| 165 | ORIC | ORIC Pharmaceuticals, Inc. | 974.48M | -4.71% | 769,894 | - |
| 166 | GERN | Geron Corporation | 974.17M | -0.65% | 7,114,713 | 183.88M |
| 167 | SANA | Sana Biotechnology, Inc. | 906.81M | 1.38% | 1,359,903 | - |
| 168 | EVMN | Evommune, Inc. | 906.40M | 0.66% | 119,149 | 13.00M |
| 169 | PHAT | Phathom Pharmaceuticals, Inc. | 905.50M | -1.64% | 1,036,596 | 175.11M |
| 170 | CTMX | CytomX Therapeutics, Inc. | 904.52M | -3.15% | 2,168,266 | 76.20M |
| 171 | MRVI | Maravai LifeSciences Holdings, Inc. | 903.59M | -4.48% | 441,036 | 185.74M |
| 172 | LBRX | LB Pharmaceuticals Inc | 898.12M | -1.54% | 67,764 | - |
| 173 | XNCR | Xencor, Inc. | 888.13M | -7.56% | 535,673 | 125.58M |
| 174 | JANX | Janux Therapeutics, Inc. | 877.80M | -5.25% | 658,178 | 10.00M |
| 175 | DRUG | Bright Minds Biosciences Inc. | 873.45M | -4.20% | 177,828 | - |
| 176 | TBPH | Theravance Biopharma, Inc. | 867.66M | 0.24% | 184,252 | 107.46M |
| 177 | SLS | SELLAS Life Sciences Group, Inc. | 862.00M | -1.64% | 2,608,514 | - |
| 178 | MNKD | MannKind Corporation | 860.00M | 5.89% | 4,051,995 | 348.97M |
| 179 | TENX | Tenax Therapeutics, Inc. | 852.85M | -4.14% | 760,622 | - |
| 180 | MGTX | MeiraGTx Holdings plc | 847.82M | 0.33% | 369,726 | 81.39M |
| 181 | ANRO | Alto Neuroscience, Inc. | 843.19M | -0.89% | 77,150 | - |
| 182 | ABUS | Arbutus Biopharma Corporation | 812.38M | -3.62% | 520,480 | 14.08M |
| 183 | CBIO | Crescent Biopharma, Inc. | 800.49M | -4.21% | 41,368 | 10.84M |
| 184 | SPRY | ARS Pharmaceuticals, Inc. | 793.39M | 0.50% | 819,407 | 84.28M |
| 185 | DSGN | Design Therapeutics, Inc. | 792.49M | 0.31% | 99,708 | - |
| 186 | KURA | Kura Oncology, Inc. | 783.77M | -2.65% | 666,666 | 67.48M |
| 187 | CGEM | Cullinan Therapeutics, Inc. | 775.34M | -3.32% | 287,546 | - |
| 188 | VOR | Vor Biopharma Inc. | 774.31M | 1.20% | 267,868 | - |
| 189 | SGP | SpyGlass Pharma, Inc. | 763.13M | -3.47% | 11,269 | - |
| 190 | ALLO | Allogene Therapeutics, Inc. | 756.75M | -2.22% | 4,134,912 | 22.00K |
| 191 | ABSI | Absci Corporation | 754.39M | 1.65% | 5,848,522 | 2.80M |
| 192 | RLMD | Relmada Therapeutics, Inc. | 743.66M | 0.85% | 618,866 | - |
| 193 | TRAX | First Tracks Biotherapeutics, Inc. | 731.81M | 16.35% | 352,477 | - |
| 194 | SLDB | Solid Biosciences Inc. | 728.12M | -1.33% | 397,182 | - |
| 195 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 707.49M | 0.57% | 372,046 | - |
| 196 | LXRX | Lexicon Pharmaceuticals, Inc. | 705.43M | -1.48% | 737,139 | 49.80M |
| 197 | GYRE | Gyre Therapeutics, Inc. | 697.56M | 0.12% | 30,570 | 116.59M |
| 198 | ARVN | Arvinas, Inc. | 654.32M | -0.58% | 213,890 | 262.60M |
| 199 | PRME | Prime Medicine, Inc. | 653.42M | 0.54% | 1,125,803 | 4.63M |
| 200 | FBRX | Forte Biosciences, Inc. | 650.26M | -0.88% | 188,382 | - |
| 201 | DRTS | Alpha Tau Medical Ltd. | 649.51M | -6.70% | 400,787 | - |
| 202 | PRTA | Prothena Corporation plc | 613.16M | 5.56% | 268,331 | 9.68M |
| 203 | CRMD | CorMedix Inc. | 594.88M | -3.01% | 754,506 | 311.71M |
| 204 | ZVRA | Zevra Therapeutics, Inc. | 585.83M | 1.02% | 362,026 | 106.47M |
| 205 | STRO | Sutro Biopharma, Inc. | 585.15M | 5.15% | 147,157 | 102.48M |
| 206 | ACRS | Aclaris Therapeutics, Inc. | 583.08M | -4.88% | 1,327,170 | 7.83M |
| 207 | RIGL | Rigel Pharmaceuticals, Inc. | 572.14M | 1.47% | 167,056 | 294.28M |
| 208 | OCGN | Ocugen, Inc. | 568.71M | -1.18% | 3,419,808 | 4.41M |
| 209 | STTK | Shattuck Labs, Inc. | 566.86M | -2.85% | 244,693 | 1.00M |
| 210 | PROK | ProKidney Corp. | 557.12M | -0.81% | 188,647 | 893.00K |
| 211 | ALT | Altimmune, Inc. | 535.99M | -1.43% | 2,676,818 | 41.00K |
| 212 | KYTX | Kyverna Therapeutics, Inc. | 527.82M | -3.00% | 510,055 | - |
| 213 | AGMB | AgomAb Therapeutics NV | 511.74M | -7.24% | 93,608 | - |
| 214 | TECX | Tectonic Therapeutic, Inc. | 510.54M | -5.43% | 84,822 | - |
| 215 | UPB | Upstream Bio, Inc. | 509.37M | 0.75% | 253,627 | 2.85M |
| 216 | LYEL | Lyell Immunopharma, Inc. | 505.41M | -4.22% | 37,656 | 36.00K |
| 217 | MDXG | MiMedx Group, Inc. | 502.90M | 1.35% | 776,384 | 418.63M |
| 218 | ZURA | Zura Bio Limited | 498.12M | -2.96% | 222,385 | - |
| 219 | FULC | Fulcrum Therapeutics, Inc. | 497.75M | -3.24% | 400,086 | 80.00M |
| 220 | XOMA | XOMA Royalty Corporation | 494.15M | -1.19% | 464,830 | 52.15M |
| 221 | VALN | Valneva SE | 491.15M | 0.02% | 26,165 | 205.07M |
| 222 | FDMT | 4D Molecular Therapeutics, Inc. | 482.44M | - | 204,364 | 85.21M |
| 223 | VSTM | Verastem, Inc. | 479.62M | -1.44% | 1,164,747 | 30.91M |
| 224 | ADCT | ADC Therapeutics SA | 476.32M | -0.40% | 441,250 | 81.36M |
| 225 | OVID | Ovid Therapeutics Inc. | 470.66M | 1.12% | 1,009,907 | 7.25M |
| 226 | CTNM | Contineum Therapeutics, Inc. | 469.13M | -3.12% | 84,872 | - |
| 227 | ENGN | enGene Therapeutics Inc. | 466.58M | -3.26% | 1,573,036 | - |
| 228 | ANL | Adlai Nortye Ltd. | 466.00M | -12.08% | 943,771 | 5.00M |
| 229 | IMMX | Immix Biopharma, Inc. | 459.08M | -9.13% | 443,792 | - |
| 230 | TRDA | Entrada Therapeutics, Inc. | 458.28M | -1.77% | 79,315 | 25.42M |
| 231 | LRMR | Larimar Therapeutics, Inc. | 457.08M | -0.90% | 983,143 | - |
| 232 | DNA | Ginkgo Bioworks Holdings, Inc. | 455.18M | - | 251,397 | 170.16M |
| 233 | CADL | Candel Therapeutics, Inc. | 453.03M | -1.67% | 452,820 | - |
| 234 | EIKN | Eikon Therapeutics, Inc. | 446.91M | -5.55% | 165,586 | - |
| 235 | RGNX | REGENXBIO Inc. | 446.49M | 0.35% | 268,637 | 170.44M |
| 236 | EPRX | Eupraxia Pharmaceuticals Inc. | 445.74M | -1.39% | 168,311 | - |
| 237 | AURA | Aura Biosciences, Inc. | 444.90M | -0.43% | 67,523 | - |
| 238 | CLYM | Climb Bio, Inc. | 441.38M | -2.74% | 2,345,755 | - |
| 239 | AVIR | Atea Pharmaceuticals, Inc. | 439.79M | 2.99% | 216,091 | - |
| 240 | ASMB | Assembly Biosciences, Inc. | 431.15M | -1.24% | 32,882 | 72.30M |
| 241 | NGNE | Neurogene Inc. | 430.21M | 1.85% | 79,458 | 925.00K |
| 242 | PRTC | PureTech Health plc | 427.41M | 2.02% | 12,623 | 6.39M |
| 243 | PRLD | Prelude Therapeutics Incorporated | 426.34M | -6.19% | 278,713 | 12.14M |
| 244 | LXEO | Lexeo Therapeutics, Inc. | 424.15M | 1.78% | 196,690 | - |
| 245 | BNTC | Benitec Biopharma Inc. | 421.85M | -2.34% | 41,907 | - |
| 246 | VNDA | Vanda Pharmaceuticals Inc. | 404.30M | 0.74% | 634,703 | 216.11M |
| 247 | NMRA | Neumora Therapeutics, Inc. | 399.17M | -1.58% | 444,673 | - |
| 248 | IVVD | Invivyd, Inc. | 397.34M | -3.77% | 663,886 | 53.43M |
| 249 | IPSC | Century Therapeutics, Inc. | 397.03M | -2.00% | 288,692 | 109.16M |
| 250 | ENTA | Enanta Pharmaceuticals, Inc. | 395.82M | 2.71% | 50,216 | 66.98M |
| 251 | AUTL | Autolus Therapeutics plc | 395.22M | 4.58% | 1,170,569 | 75.39M |
| 252 | LCTX | Lineage Cell Therapeutics, Inc. | 392.31M | 1.61% | 857,017 | 14.56M |
| 253 | NAGE | Niagen Bioscience, Inc. | 388.80M | -2.32% | 409,077 | 129.42M |
| 254 | VTVT | vTv Therapeutics Inc. | 387.18M | 6.12% | 85,777 | 17.00K |
| 255 | PBYI | Puma Biotechnology, Inc. | 382.08M | - | 134,594 | 228.37M |
| 256 | RCKT | Rocket Pharmaceuticals, Inc. | 378.66M | -0.57% | 2,526,961 | - |
| 257 | XFOR | X4 Pharmaceuticals, Inc. | 372.76M | -2.62% | 159,002 | 35.11M |
| 258 | SLN | Silence Therapeutics plc | 364.17M | -1.41% | 171,955 | 559.00K |
| 259 | MNPR | Monopar Therapeutics Inc. | 363.72M | 0.61% | 48,936 | - |
| 260 | SRZN | Surrozen, Inc. | 358.50M | 4.21% | 74,175 | 3.48M |
| 261 | IRD | Opus Genetics, Inc. | 357.73M | -2.15% | 976,647 | 14.20M |
| 262 | YDES | YD Bio Limited | 355.82M | -7.33% | 14,604 | 510.36K |
| 263 | AVTX | Avalo Therapeutics, Inc. | 351.56M | -8.74% | 488,334 | 59.00K |
| 264 | IMRX | Immuneering Corporation | 347.10M | -6.86% | 704,160 | - |
| 265 | ARMP | Armata Pharmaceuticals, Inc. | 342.52M | -15.00% | 95,101 | 4.90M |
| 266 | DMAC | DiaMedica Therapeutics Inc. | 337.84M | -0.79% | 55,369 | - |
| 267 | CMPX | Compass Therapeutics, Inc. | 334.06M | 3.63% | 29,246,128 | 850.00K |
| 268 | PALI | Palisade Bio, Inc. | 330.66M | 0.77% | 3,215,815 | - |
| 269 | NAUT | Nautilus Biotechnology, Inc. | 329.07M | 1.17% | 292,498 | - |
| 270 | BCYC | Bicycle Therapeutics plc | 325.53M | -2.10% | 219,290 | 72.59M |
| 271 | RZLT | Rezolute, Inc. | 320.96M | -6.65% | 996,001 | - |
| 272 | IKT | Inhibikase Therapeutics, Inc. | 319.60M | -0.79% | 361,222 | 1.00 |
| 273 | GLSI | Greenwich LifeSciences, Inc. | 317.68M | -4.42% | 56,529 | - |
| 274 | CABA | Cabaletta Bio, Inc. | 315.60M | -2.58% | 2,300,710 | - |
| 275 | NGEN | NervGen Pharma Corp. | 314.01M | 0.78% | 101,481 | - |
| 276 | AVXL | Anavex Life Sciences Corp. | 312.30M | 2.43% | 386,786 | - |
| 277 | ABEO | Abeona Therapeutics Inc. | 303.18M | -0.19% | 199,970 | 5.82M |
| 278 | FHTX | Foghorn Therapeutics Inc. | 302.60M | -1.06% | 89,890 | 30.91M |
| 279 | EDIT | Editas Medicine, Inc. | 300.47M | 6.23% | 780,224 | 40.52M |
| 280 | ACIU | AC Immune SA | 298.10M | 5.81% | 248,429 | 4.51M |
| 281 | ZNTL | Zentalis Pharmaceuticals, Inc. | 294.36M | -2.35% | 876,647 | 26.87M |
| 282 | CLLS | Cellectis S.A. | 291.55M | 1.00% | 4,012 | 79.59M |
| 283 | LENZ | LENZ Therapeutics, Inc. | 290.03M | -5.23% | 536,804 | 19.09M |
| 284 | NBP | NovaBridge Biosciences | 279.87M | -0.41% | 135,768 | - |
| 285 | NERV | Minerva Neurosciences, Inc. | 278.62M | -1.17% | 74,757 | - |
| 286 | CHRS | Coherus Oncology, Inc. | 272.19M | -4.08% | 455,488 | 42.17M |
| 287 | SGMT | Sagimet Biosciences Inc. | 272.09M | 2.83% | 2,676,887 | - |
| 288 | TARA | Protara Therapeutics, Inc. | 269.88M | - | 267,377 | - |
| 289 | CCCC | C4 Therapeutics, Inc. | 268.83M | -2.65% | 1,156,766 | 35.95M |
| 290 | ELDN | Eledon Pharmaceuticals, Inc. | 267.78M | 1.88% | 696,850 | - |
| 291 | PLYX | Polaryx Therapeutics, Inc. | 263.70M | 9.86% | 35,016 | - |
| 292 | ALEC | Alector, Inc. | 261.56M | 0.85% | 173,226 | 21.05M |
| 293 | HELP | Cybin Inc. | 258.69M | -4.26% | 795,580 | - |
| 294 | CGEN | Compugen Ltd. | 255.30M | -7.53% | 628,653 | 72.76M |
| 295 | ARCT | Arcturus Therapeutics Holdings Inc. | 250.69M | 6.27% | 281,977 | 82.03M |
| 296 | SABS | SAB Biotherapeutics, Inc. | 247.72M | 1.59% | 164,243 | 114.70K |
| 297 | CDXS | Codexis, Inc. | 246.71M | 2.45% | 833,286 | 70.39M |
| 298 | SLGL | Sol-Gel Technologies Ltd. | 235.22M | -6.55% | 28,322 | 19.39M |
| 299 | FENC | Fennec Pharmaceuticals Inc. | 233.05M | -1.31% | 24,199 | 44.64M |
| 300 | NVCT | Nuvectis Pharma, Inc. | 231.27M | -0.23% | 23,323 | - |
| 301 | ADAG | Adagene Inc. | 230.59M | -1.97% | 131,460 | 7.67M |
| 302 | MIST | Milestone Pharmaceuticals Inc. | 228.74M | 0.27% | 419,094 | 1.55M |
| 303 | HRTX | Heron Therapeutics, Inc. | 228.25M | 1.68% | 1,641,949 | 154.90M |
| 304 | OBIO | Orchestra BioMed Holdings, Inc. | 228.23M | -4.88% | 132,237 | 33.48M |
| 305 | CAMP | Camp4 Therapeutics Corporation | 226.89M | -1.58% | 22,772 | 3.50M |
| 306 | ARTV | Artiva Biotherapeutics, Inc. | 224.67M | -15.44% | 199,481 | 251.00K |
| 307 | KROS | Keros Therapeutics, Inc. | 224.19M | 3.27% | 162,148 | 244.06M |
| 308 | VYGR | Voyager Therapeutics, Inc. | 224.09M | - | 164,845 | 40.37M |
| 309 | ACHV | Achieve Life Sciences, Inc. | 223.87M | 6.19% | 930,380 | - |
| 310 | CNTX | Context Therapeutics Inc. | 222.81M | 3.63% | 604,704 | - |
| 311 | REPL | Replimune Group, Inc. | 218.82M | -1.12% | 3,392,622 | - |
| 312 | ALXO | ALX Oncology Holdings Inc. | 216.64M | 1.26% | 529,831 | - |
| 313 | MDWD | MediWound Ltd. | 212.70M | -0.12% | 18,503 | 16.96M |
| 314 | OKUR | OnKure Therapeutics, Inc. | 210.06M | 4.21% | 76,140 | - |
| 315 | ENLV | Enlivex Ltd. | 207.48M | -0.94% | 261,937 | - |
| 316 | OABI | OmniAb, Inc. | 203.42M | -2.43% | 229,621 | 18.67M |
| 317 | CRBU | Caribou Biosciences, Inc. | 201.49M | -2.11% | 666,829 | 11.16M |
| 318 | WHWK | Whitehawk Therapeutics, Inc. | 198.70M | 1.20% | 115,702 | 7.15M |
| 319 | ELTX | Elicio Therapeutics, Inc. | 198.68M | -4.93% | 77,737 | - |
| 320 | NKTX | Nkarta, Inc. | 198.19M | -1.77% | 282,277 | - |
| 321 | KPTI | Karyopharm Therapeutics Inc. | 194.32M | -0.46% | 152,957 | 146.07M |
| 322 | MGNX | MacroGenics, Inc. | 191.63M | -1.15% | 287,520 | 149.50M |
| 323 | CNTN | Canton Strategic Holdings, Inc. | 189.23M | 0.91% | 570,792 | - |
| 324 | KRRO | Korro Bio, Inc. | 184.97M | -0.12% | 27,684 | 6.39M |
| 325 | HUMA | Humacyte, Inc. | 183.52M | 2.57% | 4,214,551 | 2.04M |
| 326 | RNAC | Cartesian Therapeutics, Inc. | 182.91M | -2.68% | 63,683 | 2.80M |
| 327 | DTIL | Precision BioSciences, Inc. | 181.40M | -0.14% | 58,813 | 34.26M |
| 328 | UNCY | Unicycive Therapeutics, Inc. | 180.95M | -0.83% | 191,249 | - |
| 329 | ABOS | Acumen Pharmaceuticals, Inc. | 180.17M | -0.99% | 133,842 | - |
| 330 | TNXP | Tonix Pharmaceuticals Holding Corp. | 178.85M | -1.95% | 190,733 | 13.11M |
| 331 | ANTX | AN2 Therapeutics, Inc. | 175.66M | 1.67% | 152,929 | - |
| 332 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 174.88M | -2.18% | 131,056 | - |
| 333 | MENS | Jyong Biotech Ltd. | 172.26M | 4.19% | 47,503 | - |
| 334 | PLX | Protalix BioTherapeutics, Inc. | 170.81M | -1.85% | 248,182 | 52.74M |
| 335 | ORMP | Oramed Pharmaceuticals Inc. | 162.59M | -2.19% | 172,183 | 2.00M |
| 336 | MOLN | Molecular Partners AG | 159.72M | -2.30% | 740 | 856.30K |
| 337 | TLSA | Tiziana Life Sciences Ltd | 156.98M | -2.38% | 265,599 | - |
| 338 | SPRO | Spero Therapeutics, Inc. | 155.73M | 0.75% | 146,571 | 66.80M |
| 339 | BDTX | Black Diamond Therapeutics, Inc. | 155.25M | -7.19% | 531,056 | 70.00M |
| 340 | ALPS | Alps Group Inc | 153.25M | 0.11% | 3,814 | 3.74M |
| 341 | GALT | Galectin Therapeutics Inc. | 152.39M | -2.32% | 98,909 | - |
| 342 | TNYA | Tenaya Therapeutics, Inc. | 151.40M | -0.33% | 2,237,906 | - |
| 343 | FATE | Fate Therapeutics, Inc. | 151.14M | -0.76% | 556,718 | 6.65M |
| 344 | AGEN | Agenus Inc. | 150.71M | -4.03% | 528,004 | 114.20M |
| 345 | PRQR | ProQR Therapeutics N.V. | 150.67M | -4.03% | 1,117,132 | 19.19M |
| 346 | SPRB | Spruce Biosciences, Inc. | 145.95M | -5.54% | 52,022 | 697.00K |
| 347 | KZIA | Kazia Therapeutics Limited | 140.55M | 2.93% | 166,678 | 1.27M |
| 348 | IMUX | Immunic, Inc. | 138.42M | 6.31% | 309,987 | - |
| 349 | CNTB | Connect Biopharma Holdings Limited | 137.35M | -0.82% | 124,368 | 64.00K |
| 350 | ACOG | Alpha Cognition Inc. | 137.18M | -2.02% | 79,137 | 10.22M |
| 351 | HURA | TuHURA Biosciences, Inc. | 136.06M | -3.60% | 730,753 | - |
| 352 | EQ | Equillium, Inc. | 130.25M | 0.98% | 133,357 | 4.39M |
| 353 | KLRS | Kalaris Therapeutics, Inc. | 127.25M | -7.81% | 131,853 | - |
| 354 | IPHA | Innate Pharma S.A. | 127.25M | -0.71% | 10,550 | 10.57M |
| 355 | EDSA | Edesa Biotech, Inc. | 123.78M | 24.71% | 3,582,932 | - |
| 356 | IFRX | InflaRx N.V. | 122.17M | 4.97% | 3,426,855 | 34.44K |
| 357 | AARD | Aardvark Therapeutics, Inc. | 119.12M | -1.09% | 67,833 | - |
| 358 | CRDF | Cardiff Oncology, Inc. | 115.88M | -1.45% | 435,731 | 593.00K |
| 359 | BMEA | Biomea Fusion, Inc. | 115.68M | -7.51% | 1,762,197 | - |
| 360 | CGTX | Cognition Therapeutics, Inc. | 115.27M | 0.78% | 394,841 | - |
| 361 | VANI | Vivani Medical, Inc. | 113.43M | -3.60% | 129,712 | - |
| 362 | VRCA | Verrica Pharmaceuticals Inc. | 113.21M | -3.44% | 13,311 | 35.58M |
| 363 | GNLX | Genelux Corporation | 112.71M | -0.78% | 64,509 | 8.00K |
| 364 | TTRX | Turn Therapeutics Inc. | 109.92M | -0.27% | 1,438 | - |
| 365 | SEER | Seer, Inc. | 109.46M | -0.51% | 341,627 | 16.58M |
| 366 | PEPG | PepGen Inc. | 108.49M | -1.89% | 308,601 | - |
| 367 | CBUS | Cibus, Inc. | 107.56M | -5.37% | 109,196 | 3.64M |
| 368 | PYXS | Pyxis Oncology, Inc. | 106.83M | -3.40% | 254,997 | 13.86M |
| 369 | ONCY | Oncolytics Biotech Inc. | 105.68M | -6.06% | 1,070,606 | - |
| 370 | KALA | KALA BIO, Inc. | 104.94M | -5.44% | 4,028,127 | - |
| 371 | GUTS | Fractyl Health, Inc. | 104.07M | 0.44% | 943,292 | 3.00K |
| 372 | NTHI | NeOnc Technologies Holdings, Inc. | 103.38M | -9.98% | 87,167 | 39.99K |
| 373 | COYA | Coya Therapeutics, Inc. | 99.93M | -3.18% | 43,229 | 7.95M |
| 374 | ANIX | Anixa Biosciences, Inc. | 98.57M | -1.01% | 105,499 | - |
| 375 | PMN | ProMIS Neurosciences, Inc. | 98.20M | -1.35% | 30,940 | - |
| 376 | NRXP | NRx Pharmaceuticals, Inc. | 97.95M | -2.15% | 545,603 | 1.23M |
| 377 | ALDX | Aldeyra Therapeutics, Inc. | 95.99M | 0.95% | 495,512 | - |
| 378 | INO | Inovio Pharmaceuticals, Inc. | 95.05M | -0.85% | 803,892 | 65.34K |
| 379 | NRXS | NeurAxis, Inc. | 89.68M | -4.12% | 87,937 | 3.57M |
| 380 | EXOZ | eXoZymes, Inc. | 87.55M | -2.59% | 971 | -700.00 |
| 381 | RANI | Rani Therapeutics Holdings, Inc. | 85.33M | -3.93% | 280,435 | 1.63M |
| 382 | PYPD | PolyPid Ltd. | 84.92M | -2.84% | 7,098 | - |
| 383 | PTHS | Pelthos Therapeutics Inc. | 83.81M | 0.84% | 36,528 | 16.80M |
| 384 | LONA | LeonaBio, Inc. | 83.10M | 5.95% | 10,327 | - |
| 385 | QTTB | Q32 Bio Inc. | 82.80M | 3.47% | 106,759 | 53.74M |
| 386 | ACET | Adicet Bio, Inc. | 82.61M | -3.09% | 41,922 | - |
| 387 | CSBR | Champions Oncology, Inc. | 82.21M | -1.66% | 8,133 | 57.95M |
| 388 | OKYO | OKYO Pharma Limited | 82.13M | -0.95% | 8,807 | - |
| 389 | SGMO | Sangamo Therapeutics, Inc. | 80.66M | -7.29% | 2,837,206 | 39.55M |
| 390 | GOSS | Gossamer Bio, Inc. | 80.13M | -2.04% | 6,257,571 | 48.47M |
| 391 | GANX | Gain Therapeutics, Inc. | 79.20M | -3.85% | 353,259 | - |
| 392 | XBIT | XBiotech Inc. | 78.66M | 0.19% | 19,741 | - |
| 393 | ATHE | Alterity Therapeutics Limited | 78.18M | -2.16% | 19,358 | 4.43M |
| 394 | ATYR | aTyr Pharma, Inc. | 77.48M | -0.09% | 411,178 | 190.00K |
| 395 | MAIA | MAIA Biotechnology, Inc. | 77.05M | 2.42% | 227,988 | - |
| 396 | PMVP | PMV Pharmaceuticals, Inc. | 76.26M | -0.69% | 123,512 | - |
| 397 | TCRX | TScan Therapeutics, Inc. | 76.03M | -3.44% | 410,459 | 10.33M |
| 398 | FLNA | Filana Therapeutics, Inc. | 75.84M | 0.64% | 164,528 | - |
| 399 | ICCC | ImmuCell Corporation | 75.55M | 1.23% | 18,947 | 27.64M |
| 400 | PLRX | Pliant Therapeutics, Inc. | 74.92M | - | 217,309 | - |
| 401 | ACRV | Acrivon Therapeutics, Inc. | 72.84M | - | 433,791 | - |
| 402 | OSTX | OS Therapies Incorporated | 71.68M | -3.67% | 957,349 | - |
| 403 | IBO | Impact BioMedical Inc. | 71.36M | 0.27% | 40,060 | 32.00K |
| 404 | FBIO | Fortress Biotech, Inc. | 71.17M | -2.64% | 165,586 | 63.26M |
| 405 | ACTU | Actuate Therapeutics, Inc. | 69.00M | 2.11% | 97,121 | - |
| 406 | MCRB | Seres Therapeutics, Inc. | 68.47M | -2.42% | 37,456 | 789.00K |
| 407 | MNOV | MediciNova, Inc. | 67.62M | 0.28% | 26,169 | 409.66K |
| 408 | ESLA | Estrella Immunopharma, Inc. | 67.41M | -5.95% | 13,946 | - |
| 409 | IMMP | Immutep Limited | 66.75M | -10.39% | 1,922,449 | 5.28M |
| 410 | IMA | ImageneBio, Inc. | 65.26M | 0.09% | 41,942 | 800.00K |
| 411 | BYSI | BeyondSpring Inc. | 64.97M | 1.28% | 1,739 | 1.88M |
| 412 | ANVS | Annovis Bio, Inc. | 64.92M | -0.53% | 1,095,339 | - |
| 413 | HYFT | MindWalk Holdings Corp. | 62.58M | 8.62% | 96,063 | 20.70M |
| 414 | IBIO | iBio, Inc. | 60.00M | -2.92% | 461,200 | 300.00K |
| 415 | PDSB | PDS Biotechnology Corporation | 59.44M | 14.52% | 1,324,428 | - |
| 416 | CING | Cingulate Inc. | 58.49M | -4.37% | 365,502 | - |
| 417 | INKT | MiNK Therapeutics, Inc. | 54.08M | -2.24% | 12,678 | - |
| 418 | MGX | Metagenomi Therapeutics, Inc. | 53.99M | -3.04% | 64,771 | 25.21M |
| 419 | KZR | Kezar Life Sciences, Inc. | 53.86M | - | 10,716 | - |
| 420 | TIL | Instil Bio, Inc. | 53.10M | -3.69% | 14,831 | - |
| 421 | ENTX | Entera Bio Ltd. | 52.68M | -1.75% | 122,692 | 42.00K |
| 422 | RADX | Radiopharm Theranostics Limited | 50.96M | -5.38% | 7,457 | 10.86M |
| 423 | TELO | Telomir Pharmaceuticals, Inc. | 49.85M | 2.11% | 76,201 | - |
| 424 | HYPD | Hyperion DeFi, Inc. | 47.73M | -4.56% | 180,812 | 813.46K |
| 425 | RLYB | Rallybio Corporation | 46.71M | 0.57% | 38,382 | 858.00K |
| 426 | ATOS | Atossa Therapeutics, Inc. | 46.54M | -0.83% | 26,374 | - |
| 427 | NTRB | Nutriband Inc. | 46.31M | -2.06% | 14,878 | 2.28M |
| 428 | XLO | Xilio Therapeutics, Inc. | 45.94M | -2.87% | 27,961 | 43.77M |
| 429 | DWTX | Dogwood Therapeutics, Inc. | 45.43M | 1.49% | 67,384 | - |
| 430 | MREO | Mereo BioPharma Group plc | 44.23M | -1.11% | 1,064,889 | 500.00K |
| 431 | CUE | Cue Biopharma, Inc. | 42.42M | -27.33% | 640,241 | 27.47M |
| 432 | LIXT | Lixte Biotechnology Holdings, Inc. | 41.71M | -5.53% | 19,270 | - |
| 433 | LITS | Lite Strategy, Inc. | 41.45M | -2.56% | 163,020 | - |
| 434 | PTN | Palatin Technologies, Inc. | 40.76M | -1.37% | 1,629 | 8.96M |
| 435 | ATRA | Atara Biotherapeutics, Inc. | 39.83M | -2.40% | 15,149 | 120.77M |
| 436 | RNTX | Rein Therapeutics Inc. | 39.82M | -4.70% | 111,962 | - |
| 437 | SNSE | Sensei Biotherapeutics, Inc. | 39.42M | -6.74% | 85,258 | - |
| 438 | ALGS | Aligos Therapeutics, Inc. | 39.23M | -1.40% | 49,692 | 2.19M |
| 439 | PSTV | Plus Therapeutics, Inc. | 39.18M | -4.67% | 96,467 | 5.21M |
| 440 | RNXT | RenovoRx, Inc. | 38.20M | -2.55% | 430,298 | 1.12M |
| 441 | ATNM | Actinium Pharmaceuticals, Inc. | 37.41M | -0.83% | 96,926 | 90.00K |
| 442 | VERU | Veru Inc. | 37.40M | -0.43% | 22,748 | 16.89M |
| 443 | INMB | INmune Bio Inc. | 37.35M | -4.42% | 103,273 | 50.00K |
| 444 | EVAX | Evaxion A/S | 36.28M | 4.07% | 31,128 | 7.53M |
| 445 | HOWL | Werewolf Therapeutics, Inc. | 35.37M | -12.30% | 727,826 | 1.14M |
| 446 | CRVO | CervoMed Inc. | 34.72M | -1.83% | 50,337 | 4.01M |
| 447 | NXTC | NextCure, Inc. | 34.07M | -0.52% | 11,472 | - |
| 448 | PLUR | Pluri Inc. | 33.42M | 2.52% | 146 | 1.34M |
| 449 | SKYE | Skye Bioscience, Inc. | 32.93M | -11.55% | 326,907 | - |
| 450 | BOLD | Boundless Bio, Inc. | 32.27M | -2.04% | 124,762 | - |
| 451 | GRCE | Grace Therapeutics, Inc. | 32.19M | -3.70% | 466,455 | - |
| 452 | DARE | Daré Bioscience, Inc. | 32.18M | -1.34% | 109,931 | 1.03M |
| 453 | IGC | IGC Pharma, Inc. | 30.53M | -3.50% | 621,004 | 1.11M |
| 454 | DYAI | Dyadic International, Inc. | 29.88M | - | 26,641 | 3.09M |
| 455 | TVRD | Tvardi Therapeutics, Inc. | 29.83M | 4.61% | 8,949 | - |
| 456 | PLRZ | Polyrizon Ltd. | 29.77M | 0.42% | 64,693 | - |
| 457 | SNTI | Senti Biosciences Holdings, Inc. | 29.67M | -10.13% | 181,797 | 22.00K |
| 458 | CELU | Celularity Inc. | 29.63M | 3.80% | 24,873 | 40.58M |
| 459 | BCTX | BriaCell Therapeutics Corp. | 29.18M | - | 87,415 | - |
| 460 | LSTA | Lisata Therapeutics, Inc. | 28.72M | 1.92% | 7,467 | 170.00K |
| 461 | KYNB | Kyntra Bio, Inc. | 28.57M | 0.43% | 951 | 6.44M |
| 462 | NEUP | Neuphoria Therapeutics Inc. | 27.82M | 0.19% | 9,443 | 14.99M |
| 463 | OTLK | Outlook Therapeutics, Inc. | 27.78M | -6.82% | 3,200,943 | 205.70K |
| 464 | APLM | Apollomics, Inc. | 27.59M | -2.58% | 6,447 | 8.99M |
| 465 | NRSN | NeuroSense Therapeutics Ltd. | 27.57M | 3.93% | 317,271 | - |
| 466 | TVGN | Tevogen Bio Holdings Inc. | 26.94M | -7.57% | 8,930 | - |
| 467 | ABVC | ABVC BioPharma, Inc. | 26.67M | -0.05% | 23,112 | 797.92K |
| 468 | QNTM | Quantum BioPharma Ltd. | 26.07M | 22.47% | 781,772 | - |
| 469 | AEON | AEON Biopharma, Inc. | 26.06M | -0.96% | 29,914 | - |
| 470 | LGVN | Longeveron Inc. | 25.98M | -1.40% | 163,112 | 1.20M |
| 471 | JSPR | Jasper Therapeutics, Inc. | 25.46M | -2.20% | 172,404 | - |
| 472 | BRNS | Barinthus Biotherapeutics plc | 25.40M | -1.29% | 7,383 | 14.97M |
| 473 | NNVC | NanoViricides, Inc. | 24.95M | -7.56% | 406,138 | - |
| 474 | CVM | CEL-SCI Corporation | 24.85M | -5.83% | 71,545 | - |
| 475 | LTRN | Lantern Pharma Inc. | 24.32M | -11.79% | 157,755 | - |
| 476 | TPST | Tempest Therapeutics, Inc. | 24.13M | -2.21% | 109,836 | - |
| 477 | OSRH | OSR Holdings, Inc. | 23.85M | -0.53% | 688,532 | 2.91M |
| 478 | VTGN | Vistagen Therapeutics, Inc. | 23.73M | 4.85% | 305,223 | 789.00K |
| 479 | MRKR | Marker Therapeutics, Inc. | 23.51M | -2.76% | 61,170 | 3.55M |
| 480 | CRIS | Curis, Inc. | 23.01M | -1.05% | 96,316 | 9.44M |
| 481 | SER | Serina Therapeutics, Inc. | 22.41M | 1.11% | 39,948 | 130.00K |
| 482 | LEXX | Lexaria Bioscience Corp. | 21.82M | -7.39% | 80,379 | 368.00K |
| 483 | ALLR | Allarity Therapeutics, Inc. | 21.75M | 0.36% | 54,929 | 320.00K |
| 484 | XCUR | Exicure, Inc. | 21.61M | -4.78% | 10,169 | 500.00K |
| 485 | VYNE | VYNE Therapeutics Inc. | 21.33M | 0.23% | 33,664 | 570.00K |
| 486 | QNCX | Quince Therapeutics, Inc. | 19.89M | -5.43% | 1,255,689 | - |
| 487 | COCP | Cocrystal Pharma, Inc. | 19.30M | - | 49,483 | - |
| 488 | PASG | Passage Bio, Inc. | 18.44M | 0.70% | 45,719 | - |
| 489 | LPCN | Lipocine Inc. | 18.37M | -3.41% | 149,342 | 1.98M |
| 490 | GNTA | Genenta Science S.p.A. | 17.91M | 2.89% | 12,518 | - |
| 491 | KTTA | Pasithea Therapeutics Corp. | 17.02M | -1.07% | 67,054 | - |
| 492 | NCEL | NewcelX Ltd. | 16.30M | -7.58% | 25,836 | - |
| 493 | CVKD | Cadrenal Therapeutics, Inc. | 16.13M | -8.07% | 38,456 | - |
| 494 | TOVX | Theriva Biologics, Inc. | 15.71M | -3.22% | 2,556,761 | - |
| 495 | INAB | IN8bio, Inc. | 15.66M | 1.92% | 30,667 | - |
| 496 | ICU | SeaStar Medical Holding Corporation | 15.58M | 2.36% | 24,149 | 1.23M |
| 497 | HIND | Vyome Holdings, Inc. | 14.95M | -0.93% | 29,734 | 319.71K |
| 498 | CTXR | Citius Pharmaceuticals, Inc. | 14.75M | -4.63% | 900,951 | 3.94M |
| 499 | HOTH | Hoth Therapeutics, Inc. | 14.15M | -5.14% | 228,017 | - |
| 500 | PHIO | Phio Pharmaceuticals Corp. | 14.00M | -0.41% | 52,979 | - |
| 501 | PBM | Psyence Biomedical Ltd. | 13.87M | -14.18% | 216,166 | - |
| 502 | MBRX | Moleculin Biotech, Inc. | 13.77M | 1.57% | 88,038 | - |
| 503 | JUNS | Jupiter Neurosciences, Inc. | 13.57M | 3.12% | 120,211 | 21.80K |
| 504 | INTS | Intensity Therapeutics, Inc. | 13.44M | 1.15% | 12,188 | - |
| 505 | BCDA | BioCardia, Inc. | 12.69M | - | 64,077 | 3.00K |
| 506 | KAPA | Kairos Pharma, Ltd. | 12.68M | -1.10% | 51,343 | - |
| 507 | CYCN | Cyclerion Therapeutics, Inc. | 12.68M | 2.39% | 72,950 | 2.07M |
| 508 | LNAI | Lunai Bioworks Inc. | 12.07M | 7.87% | 2,180,949 | - |
| 509 | TRAW | Traws Pharma, Inc. | 11.88M | 2.63% | 56,819 | 2.79M |
| 510 | CDT | CDT Equity Inc. | 11.85M | -2.01% | 14,708 | - |
| 511 | BIVI | BioVie Inc. | 11.84M | -1.26% | 50,245 | - |
| 512 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 11.17M | -1.27% | 278,298 | - |
| 513 | CLRB | Cellectar Biosciences, Inc. | 10.98M | -0.77% | 21,039 | - |
| 514 | GDTC | CytoMed Therapeutics Limited | 10.65M | -8.16% | 11,542 | 669.28K |
| 515 | IMNN | Imunon, Inc. | 10.59M | -3.57% | 37,135 | - |
| 516 | CMMB | Chemomab Therapeutics Ltd. | 10.58M | -4.58% | 31,510 | - |
| 517 | BLRX | BioLineRx Ltd. | 10.52M | 24.02% | 94,480 | 1.18M |
| 518 | ENVB | Enveric Biosciences, Inc. | 10.48M | 3.53% | 1,138,962 | - |
| 519 | KPRX | Kiora Pharmaceuticals, Inc. | 10.31M | 1.29% | 60,150 | 20.00K |
| 520 | QNRX | Quoin Pharmaceuticals, Ltd. | 9.84M | -0.09% | 43,832 | - |
| 521 | APRE | Aprea Therapeutics, Inc. | 9.49M | -3.73% | 75,906 | 285.76K |
| 522 | BOLT | Bolt Biotherapeutics, Inc. | 9.32M | -2.22% | 5,633 | 7.70M |
| 523 | CALC | CalciMedica, Inc. | 9.02M | -2.91% | 188,625 | - |
| 524 | LIMN | Liminatus Pharma, Inc. | 8.96M | -1.46% | 662,196 | - |
| 525 | NCNA | NuCana plc | 8.93M | -2.94% | 12,576 | - |
| 526 | GTBP | GT Biopharma, Inc. | 8.89M | 0.61% | 540,798 | - |
| 527 | GNPX | Genprex, Inc. | 8.38M | -2.15% | 733,085 | - |
| 528 | EVGN | Evogene Ltd. | 8.31M | 0.63% | 53,698 | 3.85M |
| 529 | MTVA | MetaVia Inc. | 8.26M | 0.63% | 101,545 | - |
| 530 | PMCB | PharmaCyte Biotech, Inc. | 8.14M | -0.55% | 43,612 | - |
| 531 | CELZ | Creative Medical Technology Holdings, Inc. | 8.02M | -4.82% | 211,652 | 6.00K |
| 532 | PCSA | Processa Pharmaceuticals, Inc. | 7.85M | -1.17% | 7,598 | - |
| 533 | RNAZ | TransCode Therapeutics, Inc. | 7.67M | -1.88% | 488 | - |
| 534 | GRDX | GridAI Technologies Corp. | 7.65M | 1.11% | 21,550 | - |
| 535 | BCAB | BioAtla, Inc. | 7.44M | -0.44% | 10,507 | 2.00M |
| 536 | INDP | Indaptus Therapeutics, Inc. | 7.42M | -3.50% | 18,391 | - |
| 537 | ACXP | Acurx Pharmaceuticals, Inc. | 7.34M | -1.48% | 64,376 | - |
| 538 | SILO | Silo Pharma, Inc. | 7.31M | 2.57% | 248,643 | 72.10K |
| 539 | IMRN | Immuron Limited | 7.28M | -4.35% | 39,822 | 4.99M |
| 540 | ADXN | Addex Therapeutics Ltd | 7.22M | -2.12% | 10,988 | 198.82K |
| 541 | XBIO | Xenetic Biosciences, Inc. | 7.19M | 3.63% | 3,868 | 2.98M |
| 542 | APM | Aptorum Group Limited | 7.14M | -2.05% | 6,386 | - |
| 543 | CANF | Can-Fite BioPharma Ltd. | 6.52M | 0.36% | 7,311 | 405.00K |
| 544 | AKTX | Akari Therapeutics, Plc | 6.51M | 2.68% | 2,108 | - |
| 545 | MLEC | Moolec Science SA | 6.49M | 10.51% | 2,880,118 | 7.83M |
| 546 | TCRT | Alaunos Therapeutics, Inc. | 6.28M | -2.22% | 36,828 | 5.00K |
| 547 | PPBT | Purple Biotech Ltd | 6.24M | -3.05% | 3,380 | - |
| 548 | FBLG | FibroBiologics, Inc. | 6.13M | -5.59% | 120,618 | - |
| 549 | ALP | Alpha Compute Corp | 5.80M | 8.69% | 5,588,614 | - |
| 550 | APVO | Aptevo Therapeutics Inc. | 5.78M | -0.61% | 17,425 | - |
| 551 | XTLB | XTL Biopharmaceuticals Ltd. | 5.72M | -4.46% | 11,162 | 968.00K |
| 552 | MBIO | Mustang Bio, Inc. | 5.71M | -0.84% | 21,065 | - |
| 553 | CLGN | CollPlant Biotechnologies Ltd. | 5.62M | -4.85% | 52,602 | 2.37M |
| 554 | BRTX | BioRestorative Therapies, Inc. | 5.62M | -5.16% | 429,295 | 359.70K |
| 555 | ELAB | PMGC Holdings Inc. | 5.59M | - | 371,472 | 590.08K |
| 556 | ERNA | Ernexa Therapeutics Inc. | 5.57M | -4.45% | 121,442 | 1,000.00 |
| 557 | BGMS | Bio Green Med Solution, Inc. | 5.33M | -0.67% | 22,693 | 747.00K |
| 558 | CDIO | Cardio Diagnostics Holdings, Inc. | 5.19M | -3.57% | 41,599 | 14.83K |
| 559 | DRMA | Dermata Therapeutics, Inc. | 5.15M | 5.79% | 29,981 | - |
| 560 | PULM | Pulmatrix, Inc. | 4.75M | -2.26% | 36,447 | 3.00K |
| 561 | SPRC | SciSparc Ltd. | 4.68M | -5.27% | 69,452 | 1.31M |
| 562 | SNGX | Soligenix, Inc. | 4.36M | -70.11% | 14,389,150 | 2.34K |
| 563 | REVB | Revelation Biosciences, Inc. | 4.35M | 1.74% | 12,645 | - |
| 564 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 4.26M | -0.31% | 11,825 | 1.41M |
| 565 | AIM | AIM ImmunoTech Inc. | 4.20M | -0.06% | 119,863 | 88.00K |
| 566 | ALZN | Alzamend Neuro, Inc. | 4.19M | 1.85% | 17,789 | - |
| 567 | VIVS | VivoSim Labs, Inc. | 4.17M | -3.99% | 253,929 | 142.00K |
| 568 | VBIO | Tivic Health Systems, Inc. | 4.03M | 5.26% | 362,574 | - |
| 569 | MTNB | Matinas BioPharma Holdings, Inc. | 3.97M | 1.64% | 3,563 | - |
| 570 | GLMD | Galmed Pharmaceuticals Ltd. | 3.91M | -4.73% | 61,670 | - |
| 571 | AZTR | Azitra, Inc. | 3.84M | 6.03% | 786,118 | 7.50K |
| 572 | ENSC | Ensysce Biosciences, Inc. | 3.55M | 0.08% | 109,406 | 5.07M |
| 573 | JAGX | Jaguar Health, Inc. | 3.45M | -12.25% | 505,474 | 11.51M |
| 574 | GRI | GRI Bio, Inc. | 3.34M | -2.94% | 19,409 | - |
| 575 | ARTL | Artelo Biosciences, Inc. | 3.27M | -7.43% | 638,924 | - |
| 576 | GOVX | GeoVax Labs, Inc. | 3.24M | 0.90% | 69,954 | 2.49M |
| 577 | DCOY | Decoy Therapeutics Inc. | 2.89M | -1.45% | 12,349 | - |
| 578 | HCWB | HCW Biologics Inc. | 2.81M | -5.01% | 1,156,610 | 54.23K |
| 579 | OGEN | Oragenics, Inc. | 2.67M | -2.14% | 31,508 | - |
| 580 | VRAX | Virax Biolabs Group Limited | 2.63M | -6.52% | 1,786,584 | 2.99K |
| 581 | CLDI | Calidi Biotherapeutics, Inc. | 2.40M | -8.51% | 146,077,431 | - |
| 582 | BBLG | Bone Biologics Corporation | 2.39M | -3.62% | 1,282 | - |
| 583 | BDRX | Biodexa Pharmaceuticals Plc | 2.24M | 3.92% | 13,778 | 104.90K |
| 584 | PPCB | Propanc Biopharma, Inc. | 2.22M | 2.80% | 663,789 | - |
| 585 | ADIL | Adial Pharmaceuticals, Inc. | 2.22M | -0.32% | 59,019 | - |
| 586 | SCNI | Scinai Immunotherapeutics Ltd. | 1.99M | -4.20% | 549,186 | 1.31M |
| 587 | SLXN | Silexion Therapeutics Corp | 1.92M | -21.24% | 250,400 | - |
| 588 | CNSP | CNS Pharmaceuticals, Inc. | 1.84M | -1.10% | 4,561 | - |
| 589 | CMND | Clearmind Medicine Inc. | 1.52M | -0.33% | 688,211 | - |
| 590 | PHGE | BiomX Inc. | 1.44M | -11.27% | 460,510 | - |
| 591 | ASBP | Aspire Biopharma Holdings, Inc. | 1.01M | -17.84% | 14,414,893 | 6.20K |
| 592 | ONCO | Onconetix, Inc. | 518.73K | 0.88% | 5,980,885 | 815.37K |
| 593 | ADTX | Aditxt, Inc. | 196.36K | -12.81% | 1,155,142 | 3.20K |